These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8786543)

  • 21. Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension.
    Planz G; Beckenbauer U; Bundschu HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):474-8. PubMed ID: 7141755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of clonidine on opiate withdrawal symptoms. Results - biochemical mechanisms (author's transl)].
    Girard M; Escande M; Granier F; Gardes JP
    Encephale; 1982; 8(1):37-48. PubMed ID: 6284474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs.
    Flacke JW; Flacke WE; Bloor BC; Olewine S
    Anesth Analg; 1983 Mar; 62(3):305-13. PubMed ID: 6829930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal.
    Azar MR; Ahmed SH; Lintz R; Gutierrez T; Stinus L; Koob GF
    J Neurosci Methods; 2004 May; 135(1-2):129-35. PubMed ID: 15020097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of naloxone to reduce the clonidine induced reduction of blood pressure and plasma noradrenaline in patients with essential hypertension.
    Bramnert M; Hökfelt B
    Acta Physiol Scand; 1983 Aug; 118(4):379-83. PubMed ID: 6314747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clonidine for the treatment of heroin withdrawal syndrome].
    Schanda H; Presslich O; Hermann P
    Wien Klin Wochenschr; 1983 Aug; 95(16):569-72. PubMed ID: 6649643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonidine and naloxone-induced opiate withdrawal: a comparison between clonidine and morphine in man.
    Fantozzi R; Luciani G; Masini E; Blandina P; Mannaioni P
    Subst Alcohol Actions Misuse; 1980; 1(4):369-73. PubMed ID: 7302789
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine and naloxone in ultrashort opiate detoxification.
    Holman PW
    Clin Pharm; 1985; 4(1):100-2. PubMed ID: 3971678
    [No Abstract]   [Full Text] [Related]  

  • 35. Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats.
    Sparber SB; Meyer DR
    Pharmacol Biochem Behav; 1978 Sep; 9(3):319-25. PubMed ID: 568805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients.
    Gold MS; Kleber HD
    Prog Clin Biol Res; 1981; 71():299-306. PubMed ID: 6276899
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice.
    Wu X; Pang G; Zhang YM; Li G; Xu S; Dong L; Stackman RW; Zhang G
    Neurosci Lett; 2015 Oct; 607():23-28. PubMed ID: 26375926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Opiate component in the realization of the vascular effects of clonidine].
    Medvedev OS
    Biull Eksp Biol Med; 1986 Jan; 101(1):52-5. PubMed ID: 3002519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of clonidine on the acute dependence response elicited in naive rats by naloxone.
    Eisenberg RM
    Life Sci; 1983 Apr; 32(14):1547-52. PubMed ID: 6682166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
    Bramnert M; Hökfelt B
    J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.